Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Tanum

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|November 8, 2006
The effect of variable cigarette consumption on the interaction with clozapine and olanzapineTore Haslemo, Per Haakon Eikeseth, Lars Tanum, et al.
The American Journal on Addictions|March 19, 2021
Chronic Pain Among Patients With an Opioid Use DisorderZill-E Huma Latif, Ingeborg Skjaervø, Kristin K Solli, et al.
European Addiction Research|August 7, 2025
Measuring personal recovery in a sample of people with opioid use disorder- psychometric properties of the Norwegian version of the Questionnaire about the process of recovery (QPR)Anne Marciuch, Regina Skar-Fröding, Kristin Klemmetsby Solli, et al.
The Clinical Neuropsychologist|September 16, 2014
Cognitive side-effects of electroconvulsive therapy in elderly depressed patientsGro Strømnes Dybedal, Lars Tanum, Kjetil Sundet, et al.
The Journal of Clinical Psychiatry|February 5, 2015
Incident users of antipsychotic agents and future use of cholesterol-lowering drugs: an observational, pharmacoepidemiologic studySilje Skrede, Ingunn F Tvete, Lars Tanum, et al.
Journal of Substance Abuse Treatment|November 14, 2021
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-upZhanna Gaulen, Jūratė Šaltytė Benth, Lars Thore Fadnes, et al.
Frontiers in Psychology|July 3, 2013
Neuropsychological functioning in late-life depressionGro Strømnes Dybedal, Lars Tanum, Kjetil Sundet, et al.
Drugs & Aging|January 5, 2013
Benzodiazepines in geriatric psychiatry: what doctors report and what patients actually useGudrun Høiseth, Kari Midtbø Kristiansen, Kristin Kvande, et al.
BMC Psychiatry|August 5, 2011
Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophreniaAlbert Bolstad, Ole A Andreassen, Jan I Røssberg, et al.
International Journal of Environmental Research and Public Health|September 23, 2022
Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release NaltrexoneAnn Tarja Karlsson, John-Kåre Vederhus, Thomas Clausen, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|November 8, 2006
The effect of variable cigarette consumption on the interaction with clozapine and olanzapineTore Haslemo, Per Haakon Eikeseth, Lars Tanum, et al.
The American Journal on Addictions|March 19, 2021
Chronic Pain Among Patients With an Opioid Use DisorderZill-E Huma Latif, Ingeborg Skjaervø, Kristin K Solli, et al.
European Addiction Research|August 7, 2025
Measuring personal recovery in a sample of people with opioid use disorder- psychometric properties of the Norwegian version of the Questionnaire about the process of recovery (QPR)Anne Marciuch, Regina Skar-Fröding, Kristin Klemmetsby Solli, et al.
The Clinical Neuropsychologist|September 16, 2014
Cognitive side-effects of electroconvulsive therapy in elderly depressed patientsGro Strømnes Dybedal, Lars Tanum, Kjetil Sundet, et al.
The Journal of Clinical Psychiatry|February 5, 2015
Incident users of antipsychotic agents and future use of cholesterol-lowering drugs: an observational, pharmacoepidemiologic studySilje Skrede, Ingunn F Tvete, Lars Tanum, et al.
Journal of Substance Abuse Treatment|November 14, 2021
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-upZhanna Gaulen, Jūratė Šaltytė Benth, Lars Thore Fadnes, et al.
Frontiers in Psychology|July 3, 2013
Neuropsychological functioning in late-life depressionGro Strømnes Dybedal, Lars Tanum, Kjetil Sundet, et al.
Drugs & Aging|January 5, 2013
Benzodiazepines in geriatric psychiatry: what doctors report and what patients actually useGudrun Høiseth, Kari Midtbø Kristiansen, Kristin Kvande, et al.
BMC Psychiatry|August 5, 2011
Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophreniaAlbert Bolstad, Ole A Andreassen, Jan I Røssberg, et al.
International Journal of Environmental Research and Public Health|September 23, 2022
Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release NaltrexoneAnn Tarja Karlsson, John-Kåre Vederhus, Thomas Clausen, et al.
Pageof 6